Although EHBP1L1 expression did not globally alter the composition of immune cells in the TME (Figure S1B,C, Supporting Information), further analysis revealed that the expression of EHBP1L1 was positively associated with immune dysfunction score as calculated by tumor immune dysfunction and exclusion (TIDE) (Figure 1I). Here, EHBP1L1 is linked to neoplasm.